US equities
|
MU
$910.36
▲+0.60%
NVDA
$216.57
▼-0.24%
TSLA
$375.06
▲+1.90%
SPCX
$147.04
▼-0.62%
META
$692.07
▼-1.90%
SNDK
$1,372.92
▲+0.13%
AMZN
$263.23
▲+0.30%
AMD
$541.25
▲+0.59%
MU
$910.36
▲+0.60%
NVDA
$216.57
▼-0.24%
TSLA
$375.06
▲+1.90%
SPCX
$147.04
▼-0.62%
META
$692.07
▼-1.90%
SNDK
$1,372.92
▲+0.13%
AMZN
$263.23
▲+0.30%
AMD
$541.25
▲+0.59%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about 7a8e8df0/bffd/5a2d/a8c1/f36231ee8443
Recent news which mentions 7a8e8df0/bffd/5a2d/a8c1/f36231ee8443
Axsome's depression drug enters competitive market after US approval
August 19, 2022
Tags
article
fbn
fox/business/health/care
From
FOX Business